Literature DB >> 18990695

Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B.

Xiu Gao1, Marta Lorinczi, Kristen S Hill, Natasha C Brooks, Hatem Dokainish, Keith Ireton, Lisa A Elferink.   

Abstract

Entry of the bacterial pathogen Listeria monocytogenes into host epithelial cells is critical for infection and virulence. One major pathway for Listeria entry involves binding of the bacterial protein Internalin B to the host receptor tyrosine kinase Met (hepatocyte growth factor receptor). Activation of Met and downstream signaling cascades is critical for Listeria entry. Internalin B is composed of several structural domains including an N-terminal leucine-rich repeat that is sufficient for binding Met and stimulating downstream signal transduction. Internalin B is monomeric, whereas the leucine-rich repeat is dimeric when expressed as an isolated fragment. The different quaternary states of Internalin B and the leucine-rich repeat suggest that these two Met ligands might cause distinct biological effects. Here we demonstrate that Internalin B and the leucine-rich repeat fragment exhibit agonist properties that differentially influence Met down-regulation in lysosomes. Specifically, Met stability is increased in response to the leucine-rich repeat fragment compared with Internalin B. Interestingly, Internalin B and the leucine-rich repeat stimulate equivalent rates of clathrin-mediated Met internalization. However, the leucine-rich repeat is defective in promoting lysosomal down-regulation of Met and instead enhances receptor recycling to the cell surface. In addition, the leucine-rich repeat causes prolonged Met activation (phosphorylation) and increased cell motility compared with Internalin B. Taken together, our findings indicate that individual domains of Internalin B differentially regulate Met trafficking. The ability of the leucine-rich repeat fragment to promote Met recycling could account for the increased cell motility induced by this ligand.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990695      PMCID: PMC2613611          DOI: 10.1074/jbc.M805989200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Identification of an early endosomal protein regulated by phosphatidylinositol 3-kinase.

Authors:  V Patki; J Virbasius; W S Lane; B H Toh; H S Shpetner; S Corvera
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Rho proteins play a critical role in cell migration during the early phase of mucosal restitution.

Authors:  M F Santos; S A McCormack; Z Guo; J Okolicany; Y Zheng; L R Johnson; G Tigyi
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  EEA1 links PI(3)K function to Rab5 regulation of endosome fusion.

Authors:  A Simonsen; R Lippé; S Christoforidis; J M Gaullier; A Brech; J Callaghan; B H Toh; C Murphy; M Zerial; H Stenmark
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

4.  Internalin B is essential for adhesion and mediates the invasion of Listeria monocytogenes into human endothelial cells.

Authors:  S K Parida; E Domann; M Rohde; S Müller; A Darji; T Hain; J Wehland; T Chakraborty
Journal:  Mol Microbiol       Date:  1998-04       Impact factor: 3.501

5.  Internalin of Listeria monocytogenes with an intact leucine-rich repeat region is sufficient to promote internalization.

Authors:  M Lecuit; H Ohayon; L Braun; J Mengaud; P Cossart
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Met -/- kidneys express epithelial cells that chemotax and form tubules in response to EGF receptor ligands.

Authors:  C Kjelsberg; H Sakurai; K Spokes; C Birchmeier; I Drummond; S Nigam; L G Cantley
Journal:  Am J Physiol       Date:  1997-02

7.  Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells.

Authors:  L Greiffenberg; W Goebel; K S Kim; I Weiglein; A Bubert; F Engelbrecht; M Stins; M Kuhn
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.

Authors:  Taro Takami; Pal Kaposi-Novak; Koichi Uchida; Luis E Gomez-Quiroz; Elizabeth A Conner; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

9.  Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF.

Authors:  M Prat; T Crepaldi; S Pennacchietti; F Bussolino; P M Comoglio
Journal:  J Cell Sci       Date:  1998-01       Impact factor: 5.285

10.  Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB.

Authors:  Hartmut H Niemann; Volker Jäger; P Jonathan G Butler; Joop van den Heuvel; Sabine Schmidt; Davide Ferraris; Ermanno Gherardi; Dirk W Heinz
Journal:  Cell       Date:  2007-07-27       Impact factor: 41.582

View more
  3 in total

1.  A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation.

Authors:  Ognoon Mungunsukh; Young H Lee; Ana P Marquez; Fabiola Cecchi; Donald P Bottaro; Regina M Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-01       Impact factor: 5.464

2.  Engineered variants of InlB with an additional leucine-rich repeat discriminate between physiologically relevant and packing contacts in crystal structures of the InlB:MET complex.

Authors:  Hartmut H Niemann; Ermanno Gherardi; Willem M Bleymüller; Dirk W Heinz
Journal:  Protein Sci       Date:  2012-09-17       Impact factor: 6.725

3.  Decorin is a novel antagonistic ligand of the Met receptor.

Authors:  Silvia Goldoni; Ashley Humphries; Alexander Nyström; Sampurna Sattar; Rick T Owens; David J McQuillan; Keith Ireton; Renato V Iozzo
Journal:  J Cell Biol       Date:  2009-05-11       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.